baber/WOPTO huggingface dataset:
Patent AU-2202699-A (AU)
Title: Apparatus to distinguish containers
Inventor: CLAWSON BURRELL E
IPC: B65D25/20
Filed: 1998-12-21
Abstract: An apparatus to facilitate identifying a container, for example, a pharmaceutical container, includes at least one member adapted to be secured, for example, removably secured, to a container and to provide indication information effective to distinguish the container when the member is secured thereto, for example, relative to an identical container without the member. The present apparatus is particularly useful in facilitating distinguishing one pharmaceutical container from one or more other pharmaceutical containers.
Patent AU-2257797-A (AU)
Title: Covered microchannels and the microfabrication thereof
Inventor: JONS STEVE D
IPC: G01N27/447
Filed: 1997-01-30
Abstract: The present invention is a covered microchannel comprising: a) a substrate; b) an etched material adhered to the substrate; and c) a silicon-carbon material adhered to the etched material in such a manner to form a covered microchannel; wherein the silicon-carbon material comprises SiO1.8-2.4 C0.3-1.0 and H0.7-4.0 containing at least one of the following functional groups: -Si-O-Si-, -Si-CH2-, -Si-H, or -Si-OH. The covered microchannel can be prepared by the steps of: a) coating a filler material onto a substrate having a groove, wherein the filler material covering the substrate fills the groove; b) removing filler material from the substrate but not from the groove; c) coating the substrate and the filler with an adhering, formable, capping material; and d) removing the filler from the groove. An etched laminate can also be used to prepare the covered microchannel. The present invention provides a covered microchannel that can be prepared under milder conditions than those previously contemplated, thereby allowing greater flexibility in the choice of material of the substrate. The covered microchannel can be used, for example, in micro-liquid or micro-gas chromatographic or electrophoretic applications.
Patent AU-2429900-A (AU)
Title: Method of determining the gas quality
Inventor: STIRNBERG DIETER
IPC: G01N21/359
Filed: 2000-01-04
Abstract: The invention relates to a method of determining mainly the compressibility number K, the standard volumetric gross calorific value H<SUB>v,n </SUB>and the standard density rho<SUB>n </SUB>of test gases using values determined from a spectrum of the test gases. The invention describes various approaches of translating the values for determining the desired values using the data of the spectrum in the operational condition to the standard reference condition using two-step iteration processes without having to subject the test gases to time-consuming treatments. The invention further relates to devices for determining the values required for the methods and which further develop devices for carrying out the methods.
Patent AU-2602195-A (AU)
Title: Copolymer-1 improvements in compositions of copolymers
Inventor: KONFINO ELIEZER
IPC: A61K38/16
Filed: 1995-05-23
Abstract: The present invention relates to an improved composition of copolymer-1 comprising copolymer-1 substantially free of species having a molecular weight of over 40 kilodaltons.
Patent AU-2605684-A (AU)
Title: Pyrethroid pharmaceutical composition
Inventor: ARIAS JOSE ANTONIO
IPC: A61K31/19
Filed: 1984-03-23
Abstract: Parasitic and viral diseases are treated with a pyrethroid preferably in the presence of alpha-pinene. Preferred compositions are extracts of pyrethrum with water, aqueous ethyl alcohol, or alpha-pinene.
Patent AU-2684100-A (AU)
Title: Speaker recognition
Inventor: DOWNEY SIMON NICHOLAS
IPC: G10L17/02
Filed: 2000-02-25
Abstract: This invention relates to an improved method and apparatus for speaker recognition. In this invention, prior to comparing feature vectors derived from speech with a stored reference model the feature vectors are processed by applying a speaker dependent transform which matches the characteristics of a particular speaker's vocal tract. Features derived from speech which has very dissimilar characteristics to those of the speaker on which the transform is dependent may be severely distorted by the transform, whereas features from speech which has similar characteristics to those of the speaker on which the transform is dependent will be distorted far less.
Patent AU-2744299-A (AU)
Title: Motion improvements in lawn mowers
Inventor: LEVIN SHALOM
IPC: B60B33/00
Filed: 1999-03-11
Abstract: A self adjusting suspension system for a blade housing. The riding cushions (3) make contact with the ground along surface. When the housing (2) is at its lowest point, a nut (10) comes in contact with a stopper (14) and thereby prevents the housing (2) from coming down any further. By rotating the nut (10) left or right against a screw (13), which is a continuation of rod (11), the lowest point of the housing (2) can be controlled.
Patent AU-2838995-A (AU)
Title: Human interleukin 6 inhibitor
IPC: A61K38/00
Filed: 1995-08-03
Abstract: A previously undescribed Interleukin-6 inhibitor activity has been successfully isolated from the supernatant of the human promyelocytic leukemia cell line HL-60. Treatment of the HL-60 cell line with cycloheximide prevents the appearance of the inhibitory activity in the cellular supernatant. Incubation of the HL-60 supernatant with trypsin destroys the activity. The above observations indicate the inhibitor is a protein. Membrane and gel filtration studies indicate the protein has a molecular weight between 10,000 and 30,000 daltons. The inhibitor was partially isolated from other proteins by dye-ligand and reverse phase chromatography.
Patent AU-2872184-A (AU)
Title: Dibenzopyran derivatives
Inventor: GRIFFITHS RONALD CONRAD
IPC: C07D311/80
Filed: 1984-05-25
Abstract: Dibenzopyran derivatives which possess antihypoxia activity are 7,8,9,10-tetrahydro-6H-dibenzo [b,d] pyranyloxyaminopropanols having the general formula: <CHEM> where X is oxygen or dialkyl in which each alkyl group contains one to seven carbons; R is hydrogen or alkyl containing one to seven carbons and A is primary, secondary or tertiary amino. Also included are pharmaceutically acceptable acid addition salts of these compounds.
Patent AU-3054189-A (AU)
Title: Polypeptide compounds having growth hormone releasing activity
Inventor: BOWERS CYRIL YARLING
IPC: C07K14/575
Filed: 1989-01-18
Abstract: Disclosed are novel polypeptide compounds which promote the release and elevation of growth hormone levels in the blood of animals. Also disclosed are methods of promoting the release and elevation of growth hormone levels in the blood of animals using the disclosed polypeptide compounds.
Patent AU-3077284-A (AU)
Title: Manufacturing steel concrete reinforcements on a high speed rod rolling mill
Inventor: ECONOMOPOULOS MARIOS
IPC: B21B45/02
Filed: 1984-07-17
Abstract: Steel concrete-reinforcing rod is manufactured on a high speed rod rolling mill including a finisher followed by a cooling device for superficial quenching. The traction applied to the product leaving the finisher and approaching the cooling device is arranged to be appropriate to the correct advancement of the rod, by increasing the drive force of the rod and/or reducing the braking forces produced in the cooling device. Braking force in the cooling device can be reduced by introducing air into the cooling water.
Patent AU-3226693-A (AU)
Title: Nonvolatile random access memory device
IPC: G11C17/00
Filed: 1992-11-24
Abstract: A random access memory (RAM) cell in 6H-SiC having storage times when all bias is removed long enough to be considered nonvolatile. The nonvolatile random access memory (NVRAM) cell comprises a bit line, a charge storage device in silicon carbide, and a transistor in silicon carbide connecting the charge storage device to the bit line. The bipolar NVRAM cell has a bipolar transistor with a base region, an emitter region, and a floating collector region, wherein the charge storage device in the bipolar NVRAM is a p-n junction adjacent the floating collector region of the cell. The metal-oxide-semiconductor (MOS) NVRAM has a MOS field effect transistor (MOSFET) with a channel region, a source region, and a drain region, wherein the charge storage device in the MOS NVRAM is a MOS capacitor adjacent the drain region of the MOSFET.
Patent AU-3403399-A (AU)
Title: Apparatus for helically assembling at least two filaments
Inventor: BRAZEAU MICHEL
IPC: B65H59/38
Filed: 1999-04-19
Abstract: An apparatus (310) for manufacturing stranded cables comprises a supply spool assembly (320, 322) having filaments wound thereon, and a flyer (316) mounted for rotation about a central axis for imparting a rotational movement to the filaments, while guiding them axially through the apparatus (310). The filaments are wound together as they pass a gathering point centrally disposed to the central axis and downstream of the flyer (316). A filament advancing assembly (16) is provided downstream of the gathering point to impart an advancing speed to the filaments. A control system allows for the control of the number of revolutions of the flyer (316) per unit length of filaments advancing through the gathering point to ensure that a constant helical pitch is obtained. The tension in the filaments is controlled by creating an adjustable opposition to the pulling action of the filament advancing assembly (16) on the filaments thereby ensuring the production of a high quality stranded cable.
Patent AU-3433100-A (AU)
Title: Method for producing 4-amino-5-chloro-1-phenyl pyridazinone-(6)
Inventor: MERKLE HANS RUPERT
IPC: C07D237/22
Filed: 2000-03-30
Abstract: In a process for preparing 4-amino-5-chloro-1-phenylpyridazin-6-one by reacting 4,5-dichloro-1-phenylpyridazin-6-one with aqueous ammonia in the presence of a catalyst, the catalyst used is soluble in the aqueous alkaline reaction medium but is essentially insoluble in the reaction medium which has been acidified after removal of the 4-amino-5-chloro-1-phenylpyridazin-6-one.The process of the present invention makes it possible for the catalyst to be recovered and reused in a simple manner.
Patent AU-3483901-A (AU)
Title: Electron-deficient nitrogen heterocycle-substituted fluorescein dyes
Inventor: UPADHYA KRISHNA
IPC: C09B11/28
Filed: 2001-02-05
Abstract: The invention provides compositions electron-deficient nitrogen heterocycle-substituted fluorescein dyes and methods in which the dyes are conjugated to substrates and used as detection labels in molecular biology experiments. The electron-deficient nitrogen heterocycles include pyridine, quinoline, pyrazine, and the like. Substrates include polynucleotides, nucleosides, nucleotides, peptides, proteins, carbohydrates, and ligands.
Patent AU-3627100-A (AU)
Title: Release strip with partible break to facilitate removal of adhesive coated strip
Inventor: DIRKSING ROBERT STANLEY
IPC: C09J7/20
Filed: 2000-03-14
Abstract: The present invention relates to a laminated structure comprising an adhesive coated strip which is mounted upon a release strip wherein the release strip includes a partible break and wherein the release strip farther includes a tab. Deflection of the release strip tab in a direction away from the adhesive coated strip generates a partial separation of the release strip tab from the general plane of the release strip at the partible break causing an edge of the adhesive coated strip to be exposed for grasping by the user. The present invention also relates to methods for removal of an adhesive coated strip from the release strip.
Patent AU-3646799-A (AU)
Title: Method for dehydrating a porous material
Inventor: BJERKE EGIL
IPC: B01D61/56
Filed: 1999-04-15
Abstract: A method for dehydrating a porous material using electro-osmosis, includes applying a pattern of D.C. voltage pulses to an anode system embedded in the porous material, wherein the anode system is electrically interactive with a cathode structure embedded in earth, and wherein the pattern of D.C. voltage pulses, has a pulse period T in a range from about 3 to about 60 seconds, and each pulse period T includes a positive pulse duration of T+ from about 0.7 T to about 0.97 T, a negative pulse duration of T- from about 0.01 T to about 0.05 T, and a neutral pulse duration of Tp from about 0.02 T to about 0.25 T. In another embodiment, each pulse period includes two or more positive pulses separated by at least one of either a negative pulse or a neutral pulse, with the positive pulse duration being the combined duration of the two positive pulses.
Patent AU-3892701-A (AU)
Title: Food bar
Inventor: SIROHI DHAN PAL
IPC: A23L7/17
Filed: 2001-04-27
Abstract: Ready-to-eat food bar consisting of agglomerated particles of one or more cooked cereal bases mainly comprising amylaceous materials and possibly milk solids which are coated with a binder mainly comprising sugars, milk solids, humectants and fat.
Patent AU-4456489-A (AU)
Title: High-solids alkyl ketene dimer dispersion
Inventor: EDWARDS DEREK WAYNE
IPC: D21H17/29
Filed: 1989-11-10
Abstract: Stabilized dispersions of alkyl ketene dimer paper sizing agents that comprise up to about 30% by weight of ketene dimer, a water soluble cationic starch, and a lignin sulfonate, and also contain about 0.15 to about 1.5% of aluminum sulfate and from about 0.1 to about 5% of a carboxylic acid having from 1 to 10 carbon atoms, a pKa of up to about 5 and a solubility of at least about 0.1 parts in 100 parts of water (the percentages being based upon the weight of the dimer), are disclosed.
Patent AU-4492193-A (AU)
Title: Bone-related sulfatase-like protein and process for its production
Inventor: TAKESHITA SUNAO
IPC: A61K36/062
Filed: 1993-08-27
Abstract: A bone-related protein named OSF-8 which is obtained from bone tissue of a mammal including mouse or human, and a process for its production. This protein is a novel naturally occurring mammal protein which belongs to a group of sulfatases. OSF-8 degrades the sulfate groups of the sugar chains of proteoglycan, which makes up the cartilage matrix, during the replacement of cartilage into bone tissue at the stage of osteogenesis. OSF-8 can be used as an agent for treating bone metabolic diseases, and its high organ specificity for bones enables its use as a diagnostic reagent for bone metabolic diseases. <IMAGE>
Patent AU-4523285-A (AU)
Title: Prostaglandin analogues, processes for their preparation and pharmaceutical compositions containing them
Inventor: IMAKI KATSUHIRO
IPC: C08B37/16
Filed: 1985-07-22
Abstract: The present invention relates to novel isomers of PGAs, PGDs, PGEs, PGFs, 6-keto-PGE<sub>1</sub>s, 6-keto-PGF<sub>1</sub>s, PGl<sub>2</sub>s, 6,9a-nitrilo-PGl<sub>1</sub>s and 6,α-methano-PGl<sub>2</sub>s, having a specific steric configuration, which are replaced by an alkyl (C<sub>1</sub> to C<sub>8</sub>)-substituted cycloalkyl (C<sub>4 </sub>to C<sub>7</sub>) group in (1S, S) form, in (1S, R) form or in cis form at the 15-, 16- or 17-position of the PG skeleton, and, alkyl esters thereof, non-toxic salts thereof, non-toxic acid addition salts thereof and cyclodextrin clathrates thereof, possessing more potent PG-like pharmacological activity than other isomers.
Patent AU-4620399-A (AU)
Title: Procedure and device for transmitting information by radio
Inventor: LUOMA ARI-MATTI
IPC: H04B1/00
Filed: 1999-06-04
Abstract: The invention concerns a procedure for transmitting one middle channel, a first side channel and a second side channel in a radio system. According to the invention, the middle channel is transmitted as a frequency-modulated (FM) radio signal modulated by a suitable frequency, a signal symmetrically amplitude-modulated (AM) with respect to the mid-frequency of the middle channel is generated, a first amplitude-modulated single side band (LSB) is formed from the amplitude-modulated signal, a second amplitude-modulated single side band (USB) is formed from the amplitude-modulated signal, the first single side band (LSB) is modulated by the information in the first side channel, thus forming two side bands for the first single side band, the second single side band (USB) is modulated by the information in the second side channel, thus forming two side bands for the second single side band, the frequency-modulated (FM) signal, the first single side band (SSB) and the second single side band (SSB) are combined in a combiner so that all three channels are transmitted simultaneously.
Patent AU-4627893-A (AU)
Title: Bioerodible contraceptive suppository
Inventor: BRITTON PETER
IPC: A61K47/38
Filed: 1993-09-10
Abstract: The invention relates to an intravaginally-dissolvable contraceptive suppository, a method of using said suppository, and an improved method of manufacturing said birth control device. The suppositories of the invention, which comprise a lyophilized foam and a contraceptive, have a dissolution time of at least about 2 hours, and up to about 24 hours, and provide superior protection against pregnancy.
Patent AU-4857290-A (AU)
Title: Selective hydrogenolysis of perhalogenated ethane derivatives
Inventor: CHEMINAL BERNARD
IPC: C07C19/12
Filed: 1990-01-17
Abstract: Manufacture of chlorofluoroethanes of formula CF3-CHFxCl2-x, where x is equal to 0 or 1, by catalytic hydrogenation of a perhaloethane of formula CF3-CFxCl3-x. 
<??>Use of a catalyst based on ruthenium deposited on a support enables the selectivity to be improved.
Patent AU-4874293-A (AU)
Title: Method and apparatus for sterilizing cartons
Inventor: SIZER CHARLES E
IPC: B65B55/08
Filed: 1993-09-30
Abstract: An ultraviolet (UV) sterilization system for food cartons is disclosed. An elongated UV lamp (6) is mounted in a housing (12). A parabolic cylinder reflector (52) is mounted in the housing with the focus of the reflector coinciding with the axis of the arc (68) in the UV lamp. The shape of the parabolic reflector directs radiation from the lamp into cartons positioned on a conveyor below the lamp. The axis of the arc is parallel to the direction of movement of the cartons on the conveyor. The front surface of the reflector also absorbs heat from the lamp and heat is removed from the reflector (52) by circulating air (Fig. 4) over the back surface of the reflector. <IMAGE>
Patent AU-4890197-A (AU)
Title: Method and security system for processing a security critical activity
Inventor: WETTERGREN CHRISTIAN
IPC: G06F1/00
Filed: 1997-10-30
Abstract: A method, a security system and a security device for data processing a security critical activity in a secure management mode, the processing method includes the steps of allocating the security device in response to a call from the processor or the input/output devices, when in a normal mode, transferring the control of the data processing to the security device and thereby entering the secure management mode, processing, with user involvement, the security critical activity on the security device, transferring the result of the data processing of the security critical activity to the processor, the input/output devices or within the security device, and transferring the control of the input/output devices and the control of the data processing from the security device to the processor and thereby again entering the normal mode.
Patent AU-4941493-A (AU)
Title: Medical preparations containing N-methylated cyclic undecapeptides
Inventor: STUCHLIC MILAN
IPC: A61K38/13
Filed: 1993-09-03
Abstract: PCT No. PCT/CZ93/00022 Sec. 371 Date Feb. 22, 1995 Sec. 102(e) Date Feb. 22, 1995 PCT Filed Sep. 3, 1993 PCT Pub. No. WO94/05312 PCT Pub. Date Mar. 17, 1994Medical preparations (drugs) containing N-methylated cyclic undecapeptides, especially for internal use, characterized by the presence of 0.1 to 20 weight parts of compounds from the group of cyclosporins (A), 0.3 to 60 weight parts of emulsifier (B) containing anhydromanitol oleylether and/or lactoglyceride and/or citrogylceride, 0.1 to 10 weight parts of emulsion stabilizer (C) containing aluminium-magnesium hydroxy-stearate as a lipogel and 0.2 to 40 weight parts of a solvent (D) composed of 1,4: 3,6-dianhydro-2,5-di-O-methyl-D-glucitole and/or 1,3-dimethyl-2-imidazolidone and/or ethanol, with the ratio A:B being equal to 1:05-1:30.
Patent AU-4944496-A (AU)
Title: Electric machine
Inventor: STROTHMANN ROLF
IPC: H02K41/03
Filed: 1996-03-01
Abstract: An electric machine includes a separately exited rotor arrangement for the generation of magnetic fields which follow one another in the movement direction of the rotor, each magnetic field corresponding to a whole magnetic period, and stator poles arranged so as to follow one another along the rotor arrangement, wherein a number of stator poles which is not a whole number is allotted to a magnetic period. A varying offset between the magnetic field periods and the stator poles caused by the difference is at least partly compensated for by a correspondingly time-delay supply of the stator pole windings.
Patent AU-5043893-A (AU)
Title: New erythromycin derivatives, their preparation process and their use as medicaments
Inventor: AGOURIDAS CONSTANTIN
IPC: A61P31/04
Filed: 1993-11-04
Abstract: A compound selected from the group consisting of a compound of the formula    <IMAGE>  I  wherein R is   <IMAGE>   m and n are individually integers from 0 to 6, A and B are individually a member selected from the group consisting of hydrogen, halogen and alkyl of 1 to 8 carbon atoms, the double bond geometry being E or Z or E+Z or A and B form a third bond between the carbon atoms to which they are attached, Ar is selected from the group consisting of a) carbocyclic aryl of up to 18 carbon atoms optionally substituted with at least one member of the group consisting of free carboxy, alkoxycarbonyl, carboxy salified with a non-toxic, pharmaceutically acceptable base, amidified carboxy, -OH, halogen, -NO2, -CN, alkyl, alkenyl, alkynyl, alkoxy, alkenyloxy, alkynyloxy, alkylthio, alkenylthio and alkynylthio of up to 12 carbon atoms, N-alkyl, N-alkenyl and N-alkynyl of up to 12 carbon atoms and cycloalkyl of 3 to 12 carbon atoms, all optionally substituted with at least one halogen and   <IMAGE>   R1 and R2 are individually selected from the group consisting of hydrogen, alkyl of 1 to 12 carbon atoms, carbocyclic aryl, aryloxy, arylthio, heterocyclic aryl and aryloxy and arylthio containing at least one heteroatom, all optionally substituted as above and b) heterocyclic aryl having at least one heteroatom optionally substituted with at least one of the above substituents, Z is hydrogen or acyl of an organic carboxylic acid of 1 to 18 carbon atoms and their non-toxic, pharmaceutically acceptable acid addition salts having antibiotic properties.
Patent AU-5104685-A (AU)
Title: Piperazine-quinoline derivatives in basic aqueous pharmaceutical preparations
Inventor: NAIK ARUNDEV HARIBHAI
IPC: A61K9/08
Filed: 1985-12-10
Abstract: Improvement in the parenteral administration of a carboxylic acid of the formula    <IMAGE>  (I)  or   <IMAGE> (II)  in which X is N, C-H or C-F, Z is O or Ch2, R1 is hydrogen, methyl, ethyl or  beta -hydroxyethyl, R2 is cyclopropyl, 2-fluoroethyl or ethyl, R3 is hydrogen or methyl, and R4 is H or methyl, is achieved through the administration of the basic salt of the acid (I, II). Surprisingly the basic salts are suitable and stable.
Patent AU-5131593-A (AU)
Title: Sanitary napkin having shaping means
Inventor: COLES PETER
IPC: A61F13/56
Filed: 1993-09-20
Abstract: In a sanitary napkin, longitudinal score lines (40-45) applied to the core and longitudinal glue lines (51-54) located adjacent to the score lines, cause controlled deformation of the sanitary napkin's absorbent core upon lateral compression and provide increased resiliency for the sanitary napkin to return to its undeformed state when the compressive forces are removed. <IMAGE>